Showing results (661-670 of 1,182) with videos related to

Sort By:
Pageof 119
Applied Health Economics and Health Policy|December 30, 2009
Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based dataCami S Sima, Katherine S Panageas, Glenn Heller, et al.
Applied Health Economics and Health Policy|November 29, 2005
The infrastructure of obesity and the obesity epidemic: implications for public policyKenneth R Stanton, Zoltan J Acs
Applied Health Economics and Health Policy|November 29, 2005
Can we use contingent valuation to assess the demand for childhood immunisation in developing countries?: a systematic review of the literatureRaymond Y T Yeung, Richard D Smith
Applied Health Economics and Health Policy|November 29, 2005
Methodological challenges posed by economic evaluations of early childhood intervention programmesStavros Petrou, Ron Gray
Applied Health Economics and Health Policy|November 29, 2005
Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the NetherlandsCornelis Boersma, Rogier M Klok, Jasper M Bos, et al.
Applied Health Economics and Health Policy|November 13, 2009
The cost effectiveness of home-based provision of antiretroviral therapy in rural UgandaElliot Marseille, James G Kahn, Christian Pitter, et al.
Applied Health Economics and Health Policy|November 13, 2009
Cost savings associated with filling a 3-month supply of prescription medicinesAtonu Rabbani, G Caleb Alexander
Applied Health Economics and Health Policy|December 4, 2018
A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control StudyMehdi Touat, Marion Opatowski, Christian Brun-Buisson, et al.
Applied Health Economics and Health Policy|December 7, 2018
Reducing Drug Wastage in Pharmaceuticals Dosed by Weight or Body Surface Areas by Optimising Vial SizesAnthony J Hatswell, Joshua K Porter
Applied Health Economics and Health Policy|December 19, 2019
Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USAMustafa Oguz, Tereza Lanitis, Xiaoyan Li, et al.
Pageof 119